Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
28.8%
operating margin TTM
37.52%
revenue TTM
272.15 Million
revenue per share TTM
1.14$
valuation ratios | |
|---|---|
| pe ratio | 25.31 |
| peg ratio | -0.85 |
| price to book ratio | 7.79 |
| price to sales ratio | 7.30 |
| enterprise value multiple | 18.85 |
| price fair value | 7.79 |
profitability ratios | |
|---|---|
| gross profit margin | 57.39% |
| operating profit margin | 37.52% |
| pretax profit margin | 35.8% |
| net profit margin | 28.8% |
| return on assets | 23.54% |
| return on equity | 34.98% |
| return on capital employed | 34.51% |
liquidity ratios | |
|---|---|
| current ratio | 6.71 |
| quick ratio | 3.74 |
| cash ratio | 1.26 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 346.63 |
| operating cycle | 459.98 |
| days of payables outstanding | 37.81 |
| cash conversion cycle | 422.17 |
| receivables turnover | 3.22 |
| payables turnover | 9.65 |
| inventory turnover | 1.05 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.13 |
| debt equity ratio | 0.17 |
| long term debt to capitalization | 0.14 |
| total debt to capitalization | 0.14 |
| interest coverage | 26.93 |
| cash flow to debt ratio | 0.63 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.12 |
| cash per share | 0.37 |
| operating cash flow per share | 0.21 |
| free cash flow operating cash flow ratio | 0.55 |
| cash flow coverage ratios | 0.63 |
| short term coverage ratios | 12.89 |
| capital expenditure coverage ratio | 2.23 |
Frequently Asked Questions
When was the last time ADMA Biologics, Inc. (NASDAQ:ADMA) reported earnings?
ADMA Biologics, Inc. (ADMA) published its most recent earnings results on 05-11-2025.
What is ADMA Biologics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ADMA Biologics, Inc. (NASDAQ:ADMA)'s trailing twelve months ROE is 34.98%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ADMA Biologics, Inc. (ADMA) currently has a ROA of 23.54%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ADMA's net profit margin stand at?
ADMA reported a profit margin of 28.8% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ADMA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.71 in the most recent quarter. The quick ratio stood at 3.74, with a Debt/Eq ratio of 0.17.